Success rates of liver transplantation (LT) and long-term patients' survival are both steadily improving during recent decades. This is largely attributed to the improvement in immunosuppression. 1 However, higher levels of immunosuppression bear the cost of both early and late infections, 2 resulting in substantial morbidity and, in extreme cases, mortality post-LT. 3 The types of infections in the first 30 days following LT are similar to those seen in general postoperative hospitalized patients, being mostly nosocomial in nature. 4 Data are showing that severe sepsis post-LT is in association with poor long-term survival. 5 Some publications demonstrate worse long-term survival for LT patients who suffered from wound infections; 6,7 however, in a large series of 910 LT patients from 2010, bacteremia, infected ascites, or urinary tract infections (UTIs) did not impact survival. 5 Another series of LT recipients even demonstrated